Buy Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml Online

Veterinary Clenbuterol Oral Syrup for Equine Respiratory Management

Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml is an oral veterinary formulation identified in commercial equine-product listings as containing clenbuterol at 72.5 micrograms per millilitre. The same concentration is used in established veterinary clenbuterol syrup products for horses.

Clenbuterol is a beta-2 adrenergic agonist with bronchodilating activity. In veterinary medicine, appropriately labelled clenbuterol products are used in horses for the management of airway obstruction. The U.S. FDA-approved reference product Ventipulmin Syrup, for example, contains clenbuterol hydrochloride 72.5 mcg/mL, is intended for oral use in horses, and is restricted to use by or on the order of a licensed veterinarian in the United States.

Because Clenbuterol Gold is a brand/product name for which I could not locate an authoritative manufacturer datasheet confirming all formulation and registration details, this page distinguishes the reported product specification from information established for other clenbuterol veterinary medicines. The exact manufacturer, excipients, registration status, approved indications, and jurisdiction-specific requirements should be confirmed from the product packaging before publication or sale.

What Is Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml?

Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml is presented in current commercial listings as an oral clenbuterol syrup for equine use, supplied in a 100 mL presentation. Listings identify the concentration as 72.5 mcg/mL.

Clenbuterol belongs to the beta-2 adrenergic agonist class. Veterinary clenbuterol products can produce bronchodilating effects, making the ingredient relevant to certain equine respiratory conditions.

An established reference for this concentration is Ventipulmin Syrup, which contains clenbuterol hydrochloride 72.5 mcg/mL and is FDA-approved for oral use in horses for management of airway obstruction such as chronic obstructive pulmonary disease.

However, Clenbuterol Gold should not automatically be represented as Ventipulmin or as an equivalent registered product unless the packaging or manufacturer documentation confirms that relationship.

That distinction is important because products containing the same active ingredient can differ in formulation, manufacturer, authorization, labeling, and legal status between countries.

Clenbuterol Gold Overview

The 72.5 mcg/mL concentration and 100 mL presentation are supported by current commercial listings for this product name.

The FDA-approved Ventipulmin reference product also uses 72.5 mcg/mL clenbuterol hydrochloride and is supplied in a 100 mL bottle, demonstrating that the stated strength and presentation are consistent with an established equine clenbuterol formulation.

That does not, by itself, establish that Clenbuterol Gold has the same manufacturer, formulation, registration, or regulatory approval.

Active Ingredient

Clenbuterol

Clenbuterol is a beta-2 adrenergic agonist with bronchodilating properties.

In veterinary medicine, its principal established equine application is associated with airway obstruction. The FDA-approved Ventipulmin label describes clenbuterol hydrochloride as providing bronchodilating activity and indicates the product for management of horses affected by airway obstruction such as COPD.

The reported concentration for Clenbuterol Gold is 72.5 mcg/mL.

The concentration should be checked against the physical product label before use, particularly because similarly named clenbuterol products can appear in different markets.

Key Features of Clenbuterol Gold Oral Syrup

The identifiable product characteristics include:

• Oral veterinary syrup.
• Reported clenbuterol concentration of 72.5 mcg/mL.
• 100 mL presentation.
• Equine-oriented product listings.
• Beta-2 adrenergic agonist formulation.
• Relevant to veterinary respiratory management.
• Requires careful consideration of veterinary, regulatory, and competition requirements.
• Exact manufacturer and registration information should be verified from the current product packaging.

The product should not be marketed as a general-purpose performance enhancer. Clenbuterol has a defined pharmacological action and significant regulatory considerations.

Clenbuterol in Equine Veterinary Medicine

Clenbuterol has an established place in equine respiratory pharmacology.

The FDA-approved Ventipulmin label identifies it for horses affected by airway obstruction, including conditions such as chronic obstructive pulmonary disease.

Respiratory disease in horses can involve airway narrowing, inflammation, mucus accumulation, hypersensitivity, or other pathological changes. A veterinarian may therefore need to evaluate the horse’s history, environment, clinical signs, exercise tolerance, and respiratory function before determining whether bronchodilator therapy is appropriate.

Clenbuterol should not be presented as an appropriate treatment for every episode of coughing, nasal discharge, exercise intolerance, or difficult breathing.

Those signs can have multiple causes, including infectious disease, inflammatory airway disease, environmental exposure, cardiac problems, and other respiratory disorders.

Respiratory and Airway Management in Horses

A horse’s respiratory system is particularly important for athletic performance because oxygen delivery becomes increasingly important as exercise intensity increases.

Respiratory abnormalities may become more noticeable during or after exercise, but the underlying cause can vary considerably.

Veterinary assessment may consider:

• Frequency and character of coughing.
• Nasal discharge.
• Breathing effort.
• Respiratory sounds.
• Exercise tolerance.
• Environmental dust and allergens.
• Stable ventilation.
• Past respiratory disease.
• Infectious exposure.
• Response to previous treatment.
• Diagnostic imaging or airway evaluation where appropriate.

Where airway obstruction has been diagnosed, a veterinarian may consider bronchodilator therapy among the available management options.

The FDA-approved clenbuterol label specifically identifies airway obstruction in horses as the therapeutic context for its approved product.

Product Form and Presentation

Clenbuterol Gold is identified by the supplied keyword as a 100 mL oral syrup containing 72.5 mcg/mL.

This is consistent with the presentation of established veterinary clenbuterol syrups. Ventipulmin, for example, is supplied in 100 mL and 330 mL bottles at 72.5 mcg clenbuterol hydrochloride per mL.

The 100 mL size can be useful for veterinary treatment plans where an oral liquid formulation has been prescribed.

Before listing the product specifications, the physical packaging should be checked for:

• Active ingredient name.
• Concentration.
• Manufacturer.
• Bottle volume.
• Batch or lot number.
• Expiration date.
• Storage instructions.
• Species.
• Approved indication.
• Prescription classification.
• Local registration information.

Veterinary Considerations

Clenbuterol is pharmacologically active and should be used differently from a nutritional supplement.

A veterinarian should first determine whether the horse’s respiratory signs are consistent with a condition for which bronchodilator therapy is appropriate.

This is especially important because airway disease can have multiple causes. Treatment directed at airway constriction may not address infection, structural abnormalities, environmental triggers, or other underlying problems.

Diagnosis Matters

Before treatment, veterinary assessment may help determine:

• Whether the problem is respiratory.
• Whether airway obstruction is present.
• Whether infection should be ruled out.
• Whether environmental management is required.
• Whether other medications are appropriate.
• Whether the horse has cardiovascular concerns.
• Whether competition rules affect treatment decisions.

Clenbuterol should therefore be regarded as one component of veterinary respiratory management rather than a universal solution for poor performance.

Benefits and Important Considerations

When appropriately prescribed for an indicated respiratory condition, the principal therapeutic rationale for clenbuterol is its bronchodilating action.

The FDA-approved reference product describes clenbuterol as a beta-2 adrenergic agonist providing bronchodilating properties.

For horses with an appropriate airway-obstruction diagnosis, bronchodilator therapy can form part of a broader management program.

However, several factors need to be considered.

It Is Not a General Performance Product

Commercial listings sometimes place clenbuterol among products associated with performance horses.

That commercial categorization should not be interpreted as an indication that clenbuterol is intended to improve athletic performance in healthy horses.

Its veterinary pharmacological role is respiratory, and its use in competition is subject to medication-control rules.

Respiratory Management May Require More Than Medication

For horses with environmentally influenced airway disease, management of dust, ventilation, bedding, forage, and other environmental factors may be important alongside veterinary treatment.

Medication should not replace investigation of potential environmental or underlying causes.

Important Safety Information

Clenbuterol can affect cardiovascular and neuromuscular function.

The FDA-approved Ventipulmin label reports possible adverse reactions including mild sweating, muscle tremor, restlessness, urticaria, and tachycardia, particularly during the first days of treatment. It also reports elevated creatine kinase and occasional ataxia in clinical studies.

These effects illustrate why clenbuterol should be used under veterinary direction.

Cardiovascular Considerations

The FDA label specifically states that Ventipulmin should not be used in horses suspected of having cardiovascular impairment because tachycardia may occur.

A veterinarian should therefore consider cardiovascular status before prescribing a clenbuterol-containing product.

Pregnancy

The FDA-approved label states that Ventipulmin should not be used in pregnant mares near term and that the effects on reproduction in breeding stallions and brood mares have not been determined.

Because this information relates specifically to the FDA-approved Ventipulmin formulation, the current label for Clenbuterol Gold should also be consulted before making product-specific reproductive claims.

Human Exposure

Clenbuterol products intended for horses are not human medicines.

The FDA label warns that accidental human ingestion can cause undesirable effects and notes that beta-adrenergic agonists can produce significant cardiovascular effects in people.

The product should therefore be kept out of reach of children and handled responsibly.

Precautions and Contraindications

The exact contraindications for Clenbuterol Gold should be taken from its current product label.

For the FDA-approved Ventipulmin formulation, relevant contraindication information includes:

• Suspected cardiovascular impairment.
• Pregnancy near term.
• Interaction considerations involving prostaglandin F2α and oxytocin.

These points demonstrate why information from one clenbuterol formulation should not automatically be copied onto another product.

The veterinarian should review the horse’s health status and concurrent medicines before treatment.

Administration and Veterinary Supervision

Clenbuterol Gold is identified as an oral syrup, and established clenbuterol veterinary syrups are administered orally to horses.

Because this is a prescription-level pharmacological product in some jurisdictions, the appropriate treatment regimen should come from the responsible veterinarian and the applicable product label.

No individualized dosing schedule is provided here.

The appropriate dose and treatment duration can depend on the specific diagnosis, product formulation, horse, regulatory jurisdiction, and veterinary treatment plan.

Customers should not substitute the dosing instructions of another clenbuterol product simply because the concentration appears similar.

Storage and Handling

For the FDA-approved Ventipulmin formulation, the labeled storage requirement is at or below 25°C (77°F), with freezing avoided.

If Clenbuterol Gold has different manufacturer instructions, those instructions should take precedence.

General handling considerations include:

• Keep the bottle properly closed.
• Follow the product’s stated storage temperature.
• Protect the product from unsuitable environmental conditions.
• Avoid freezing where the label specifies this.
• Keep the medicine away from children and unauthorized users.
• Check the bottle and label before use.
• Do not use a product with compromised packaging or an expired label.

Competition and Regulatory Considerations

This is one of the most important considerations when discussing equine clenbuterol products.

Clenbuterol is a pharmacologically active beta-2 agonist and can be relevant to medication-control programs.

The FEI has specifically identified clenbuterol in its veterinary medication-control materials. For example, an FEI competition document states that clenbuterol could not be used under the particular retrospective treatment protocol described there.

Competition rules can change and vary between organizations, disciplines, jurisdictions, and events.

Therefore:

• Do not assume therapeutic use automatically means competition-permitted use.
• Check the current rules of the relevant governing body.
• Discuss treatment timing with the attending veterinarian.
• Maintain appropriate veterinary treatment records.
• Never use clenbuterol to mask injury or circumvent medication testing.

World Equine Vet should not make claims that Clenbuterol Gold is “competition safe,” “race legal,” or “undetectable” unless a current governing-body rule specifically supports such a statement.

Food-Producing Animals

Clenbuterol also carries important food-animal restrictions.

The U.S. Ventipulmin label states that the product is for horses only and that federal law prohibits its extra-label use in food animals.

Accordingly, clenbuterol should not be presented as an appropriate medicine for animals entering the human food chain unless the applicable jurisdiction has a specific lawful veterinary framework supporting such use.

Product registration and food-animal rules vary internationally, so local veterinary authorities and the current product label should be consulted.

Purchasing Considerations

When researching Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml, buyers should verify the exact product rather than relying solely on the product name.

Check:

• Active ingredient: Clenbuterol/clenbuterol hydrochloride, as stated on the package.
• Strength: 72.5 mcg/mL.
• Presentation: 100 mL.
• Manufacturer: Confirm from the physical label.
• Registration: Verify for the destination country.
• Expiry date: Confirm before use.
• Batch number: Check against the packaging.
• Storage instructions: Follow the product-specific label.
• Prescription requirements: Follow applicable law.
• Competition requirements: Check the relevant governing body.

An important distinction is that 72.5 mcg/mL is also the strength of FDA-approved Ventipulmin, but that does not establish that Clenbuterol Gold is manufactured by Boehringer Ingelheim or has the same approval. The FDA record identifies Ventipulmin specifically as a Boehringer Ingelheim product.

Shipping and Availability

Veterinary medicines containing clenbuterol can be subject to destination-specific controls.

Before purchasing or importing the product, customers should determine whether:

• The product is legally available in their country.
• A veterinary prescription is required.
• Import authorization applies.
• The product is registered locally.
• The destination permits receipt of the medicine.
• Competition or sporting rules affect its use.

Shipping should always comply with applicable prescription, customs, veterinary-medicine, and import regulations.

No shipping method should be used to conceal a regulated medicine, bypass customs controls, or circumvent medication-testing requirements.

Where To Buy Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml Online

If you are researching where to buy Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml online, World Equine Vet can provide product information and purchasing information where lawful and permitted.

Because this is a clenbuterol-containing veterinary medicine, customers should verify the exact formulation, manufacturer, registration status, prescription requirements, and destination-country rules before purchasing.

The reported Clenbuterol Gold specification is 72.5 mcg/mL in a 100 mL oral syrup. Established veterinary products at the same concentration are prescription medicines in certain jurisdictions; for example, the U.S. FDA classifies Ventipulmin as a prescription animal drug restricted to use by or on the order of a licensed veterinarian.

Availability and lawful purchasing requirements therefore depend on the destination and the specific product registration.

Frequently Asked Questions

What is Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml?

It is a commercially listed oral veterinary syrup containing a reported 72.5 mcg/mL concentration of clenbuterol, supplied in a 100 mL presentation.

What is the active ingredient?

The active drug is clenbuterol; established veterinary formulations at this strength use clenbuterol hydrochloride. The exact salt/formulation of Clenbuterol Gold should be confirmed on its packaging before being stated as definitive.

What strength is Clenbuterol Gold?

The supplied product specification and commercial listings identify the concentration as 72.5 mcg/mL.

What size bottle is Clenbuterol Gold?

The product is identified as a 100 mL oral syrup.

What is clenbuterol used for in horses?

An FDA-approved clenbuterol syrup is indicated for management of horses affected by airway obstruction, including COPD. The appropriate indication for a particular Clenbuterol Gold product should be confirmed from its own label and veterinary registration.

Is Clenbuterol Gold a respiratory medicine?

Its active ingredient, clenbuterol, is a beta-2 adrenergic agonist with bronchodilating properties. Established equine clenbuterol products are used for respiratory airway obstruction.

Is Clenbuterol Gold a performance-enhancing product?

It should not be marketed or represented as a general performance-enhancing product. Clenbuterol has a veterinary respiratory pharmacological role, and its use can be subject to equine medication-control rules.

Does clenbuterol have side effects in horses?

Yes. The FDA label for Ventipulmin reports possible sweating, muscle tremor, restlessness, urticaria and tachycardia, among other observations.

Can clenbuterol affect the heart?

Yes. Tachycardia can occur, and the FDA-approved Ventipulmin label states that it should not be used in horses suspected of cardiovascular impairment.

Is Clenbuterol Gold prescription-only?

Prescription status depends on the product and jurisdiction. In the United States, the FDA-approved Ventipulmin formulation is a prescription animal drug restricted to use by or on the order of a licensed veterinarian.

Is clenbuterol allowed in horse competitions?

Competition rules vary. Clenbuterol is specifically addressed in FEI veterinary medication-control materials, so owners should check the current rules applicable to their event rather than assuming that therapeutic use is competition-permitted.

Can Clenbuterol Gold be used in food-producing animals?

This should not be assumed. The U.S. Ventipulmin label specifically prohibits extra-label use in food animals. Destination-specific veterinary regulations must be checked.

How should Clenbuterol Gold be stored?

Storage should follow the exact product label. For FDA-approved Ventipulmin, the labeled requirement is at or below 25°C and avoiding freezing.

Where can I buy Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml?

Availability depends on local registration, prescription requirements, and import regulations. World Equine Vet can provide product information and purchasing details where the product may lawfully be supplied.

Final Summary

Clenbuterol Gold Oral Syrup 72.5mcg/ml, 100ml is listed commercially as a 100 mL oral equine product containing 72.5 mcg/mL clenbuterol.

Clenbuterol is a beta-2 adrenergic agonist with bronchodilating properties. Established veterinary products containing the same concentration are used in horses for the management of airway obstruction.

Because the exact manufacturer documentation for Clenbuterol Gold was not located, product-specific claims beyond the reported concentration and presentation should be verified against the packaging or manufacturer documentation.

This product also requires particular attention to veterinary supervision, cardiovascular considerations, food-animal restrictions, and equine medication-control regulations. The FDA-approved reference product is prescription-only in the United States, and FEI materials demonstrate that clenbuterol can be relevant to competition medication rules.

Clenbuterol Gold Oral Syrup, 72.5mcg/ml, 100ml  is a beta-2 symphatomimetic compound and in this format it comes in a specialty syrup form.  Clenbuterol has been the subject of intensive research in both humans and domestic animals. Due to its chemical structure, a high degree of selectivity for the beta-2 receptor sites in the body has been achieved providing intense bronchodilating properties with minimal effect on the cardiovascular system.   The duration of effects of ydrochloride Injection is long-lasting and in the range of 6-8 hours after a single  application.Clenbuterol Gold Oral Syrup, 72.5mcg/ml, 100ml

Active Ingredient: l Hydrochloride 72.5mcg/ml  Inactive Ingredients: PURE cane sugar syrup (That’s why ours is GOLD.  We don’t use simple sugar syrup.), polyethyline glycol, ethyl alcohol and glycerine.

Indications: Injection is used for the treatment of respiratory disease in horses where it is considered that airway obstruction is due to  In cases accompanied by pyrexia, the parenteral administration of chemotherapeutic and/or anti-infective agents is recommended.

Dosage and Administration: Clenbuterol Gold Oral Syrup, 72.5mcg/ml, 100ml

Contraindications:  Due to a potential risk of increasing the peripheral vasodilating effect of cl, it is not recommended that corticosteroids be used in conjunction with  Injection. Hydrochloride Injection antagonizes the effects of prostaglandin F2? and oxytocin. The action of  Injection is antagonized by adrenergic blocking agents.

Caution:  If used during pregnancyInjection must be discontinued at the expected time of delivery, since uterine contractions may be abolished under its influence. The effect on fertility of breeding stallions has not been determined.

Side Effects:  Infrequently, transient sweating, muscle tremors and mild tachycardia have been observed following intravenous administration. In each instance, the symptoms abated without complications or additional treatment.

Storage:  Store below 25 C (Air Conditioning) and protect from light.